Global Health Economics & Outcomes Research, Abbott Laboratories, Abbott Park, IL 60064-6145, USA.
Curr Med Res Opin. 2010 Apr;26(4):933-41. doi: 10.1185/03007991003656968.
To determine the association between baseline HDL-C concentrations and risk of a major cardiovascular event (within 5 years) in a large US claims database.
A retrospective longitudinal analysis using claims data from the i3 Ingenix LabRx database was conducted. Patients were included if they had complete lipid panel lab results, were continuously enrolled for >or=6 months prior to and >or=12 months following the lab test (index date), and were >or=50 years of age. Cox proportional hazards analysis assessed the association between HDL-C concentrations and risk of a major cardiovascular event within 5 years of the index date, after adjusting for covariates.
There was a statistically significant association between HDL-C and risk of a major cardiovascular event. A 0.026 mmol/L (1 mg/dL) increase in HDL-C from baseline was associated with a 1.3% decreased risk of a major cardiovascular event (e.g., a 0.13 mmol/L [5 mg/dL] increase in HDL-C above baseline concentrations was associated with a 6.5% decrease). This association became evident within 1 year of follow-up.
HDL-C concentrations were inversely associated with the occurrence of cardiovascular events within 5 years. Women who were >or=0.26 mmol/L (10 mg/dL) below their target concentrations had cardiovascular risk similar to that of women with baseline ischemic heart disease and hypertension, and men who were >or=0.26 mmol/L (10 mg/dL) below their target concentrations had cardiovascular risk similar to that of men with baseline cardiovascular disease, diabetes, or cerebrovascular disease. Limitations inherent to claims-based analyses must be considered when interpreting these findings, such as the potential for miscoding or incomplete data, and the fact that the presence of a diagnosis code on a medical claim is not positive presence of disease. Furthermore, patients who suffered a fatal cardiovascular event at home during the study period, and therefore did not receive treatment, were not captured in this analysis.
在一个大型美国理赔数据库中,确定基线高密度脂蛋白胆固醇(HDL-C)浓度与主要心血管事件(5 年内)风险之间的关联。
使用 i3 Ingenix LabRx 数据库中的理赔数据进行回顾性纵向分析。纳入的患者需要具备完整的血脂检测结果,在检测(索引日期)前连续参保时间超过 6 个月且在检测后超过 12 个月,且年龄超过 50 岁。采用 Cox 比例风险分析评估了 HDL-C 浓度与索引日期后 5 年内发生主要心血管事件风险之间的关联,调整了协变量因素。
HDL-C 与主要心血管事件风险之间存在统计学显著关联。HDL-C 基线水平每升高 0.026mmol/L(1mg/dL),主要心血管事件风险降低 1.3%(例如,HDL-C 比基线浓度升高 0.13mmol/L[5mg/dL],风险降低 6.5%)。这种关联在随访 1 年内即可显现。
HDL-C 浓度与 5 年内心血管事件的发生呈负相关。HDL-C 浓度低于目标值 0.26mmol/L(10mg/dL)的女性发生心血管事件的风险与基线患有缺血性心脏病和高血压的女性相似,HDL-C 浓度低于目标值 0.26mmol/L(10mg/dL)的男性发生心血管事件的风险与基线患有心血管疾病、糖尿病或脑血管疾病的男性相似。在解释这些发现时,必须考虑到理赔分析固有的局限性,例如潜在的错误编码或数据不完整,以及医疗索赔上的诊断代码并不一定代表确实患有该疾病。此外,本分析未捕获研究期间在家中发生致命性心血管事件且未接受治疗的患者。